SK Biopharmaceuticals Co., Ltd.

KRX:326030.KS

110300 (KRW) • At close January 15, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) KRW.

2023202220212020201920182017201620152014201320122011
Assets:
Current Assets:
Cash & Cash Equivalents 239,700.042104,059.703225,922.27859,333.23951,140.94874,292.18225,271.81138,613.95168,566.96328,232.28128,190.60135,745.05936,426.11
Short Term Investments 1,418.394201,394.03108,417.05328,657.26231,233.5142,236.239,078.537130,18346,860105,396.844,221.280,00094,000
Cash and Short Term Investments 241,118.437305,453.733334,339.328387,990.50182,374.46276,528.38264,350.349168,796.951115,426.963133,629.08172,411.801115,745.059130,426.11
Net Receivables 115,846.80267,020.73355,883.29512,637.7392,546.212-015,387.5441,793.5078,921.87219,500.45617,517.80519,299.7470
Inventory 102,525.49190,919.90451,933.44223,039.7876,733.329162.283864.5929.34121,314.06616,456.07412,919.25311,922.99814,197.711
Other Current Assets 29,231.51128,045.14329,063.20315,009.5829,383.4874,867.4232,138.3423,421.9764,234.73,913.3823,169.48719,299.74719,028.02
Total Current Assets 488,722.241487,924.713471,219.268434,602.62498,680.71281,558.08981,828.085174,941.776149,022.047173,498.993106,018.345146,967.804163,651.841
Non-Current Assets:
Property, Plant & Equipment, Net 47,753.14520,349.7422,937.54124,233.20925,896.76112,153.8113,821.59215,953.79752,777.49453,226.12254,528.84455,034.7460,155.23
Goodwill 3,391.911000000000000
Intangible Assets 23,632.69617,180.83118,899.65419,695.121883.318245.974245.974198.641500.924500.924884.002884.002884.002
Goodwill and Intangible Assets 17,934.33717,180.83118,899.65419,695.121883.318245.974245.974198.641500.924500.924884.002884.002884.002
Long Term Investments 104,091.298-101,435.389-752.463-321,808.541-31,226.514-2,188.501-38,582.59-129,638.454-46,351.12-94,435.441-36,069.771-77,000.405-88,426.742
Tax Assets 44,723.36129,641.05718,919.17611,837.08813,550.3192,236.2474.153747.2454,322.321706.8191,261.8891,653.8141,383.473
Other Non-Current Assets 19,946.195210,580.189112,429.164331,681.92331,288.5381,529.95140,580.062131,691.77148,362.229105,402.73644,255.27780,034.07794,034.077
Total Non-Current Assets 234,448.336176,316.427172,433.07265,638.80140,392.42313,977.43416,539.19118,952.99959,611.84865,401.15964,860.2460,606.22768,030.041
Total Assets 723,170.577664,241.139643,652.339500,241.425139,073.13595,535.52398,367.276193,894.775208,633.895238,900.153170,878.586207,574.032231,681.882
Liabilities & Equity:
Current Liabilities:
Account Payables 2,345.80123,106.32814,933.9738,953.6130023,827.58718,518.1264,443.0871,687.1092,735.024213.51961.437
Short Term Debt 57,060.819-25,204.5465,481.443-51,724.527103,196.65600000000
Tax Payables 88.782208.3551,997.43800000000018.203
Deferred Revenue 030,848.566125,785.45356,630.3120848.075308.862000000
Other Current Liabilities 182,123.187103,265.366125,892.785105.78242,444.08930,122.26323,150.7723,047.52323,059.59115,314.6497,100.7378,648.44110,045.444
Total Current Liabilities 241,618.589163,072.636148,305.63870,595.492145,640.74530,970.33846,978.35741,565.64924,648.24717,001.7589,835.768,861.95111,025.084
Non-Current Liabilities:
Long Term Debt 120,989.231150,251.99510,256.07413,572.0995,858.35500000000
Deferred Revenue Non-Current 031,157.33538,582.21835,042.75101,466.9470665.029502.7591,948.458,667.66511,874.1711,260.496
Deferred Tax Liabilities Non-Current 1,908.95702,320.9631,964.51000000000
Other Non-Current Liabilities 37,702.60634,356.04838,582.21837,007.261599.2975,935.9854,146.1513,976.8473,268.3545,419.2672,492.6652,017.5163,520.471
Total Non-Current Liabilities 160,600.794184,608.04351,159.25550,579.3616,457.6535,935.9854,146.1524,641.8763,771.1135,419.26711,160.3313,891.6874,780.967
Total Liabilities 402,219.383347,680.679199,464.893121,174.852152,098.39836,906.32351,124.50846,207.52528,419.3622,421.02520,996.0922,753.63915,806.051
Equity:
Preferred Stock 0000000000000
Common Stock 39,156.62539,156.62539,156.62539,156.62532,50032,50025,00025,00025,00025,00020,00020,00020,000
Retained Earnings -848,319.006-827,555.385-689,141.263-746,951.075-498,947.611-426,403.366-286,861.59-189,271.407-156,386.924-128,801.744-91,206.53-49,890.855-20,266.43
Accumulated Other Comprehensive Income/Loss 21,242.8948,295.6189,324.5032,013.4427,382.8116,493.0294,899.581000000
Other Total Stockholders Equity 1,071,605.8591,084,847.5821,084,847.5821,084,847.582453,422.349446,039.537303,579.172303,579.171313,560.918320,280.871221,089.025214,711.248216,142.261
Total Shareholders Equity 283,686.371316,560.46444,187.446379,066.573-13,025.26258,629.247,242.768147,687.25180,214.535216,479.127149,882.495184,820.393215,875.831
Total Equity 320,951.195316,560.46444,187.446379,066.573-13,025.26258,629.247,242.768147,687.25180,214.535216,479.127149,882.495184,820.393215,875.831
Total Liabilities & Shareholders Equity 723,170.577664,241.139643,652.339500,241.425139,073.13595,535.52398,367.276193,894.775208,633.895238,900.152170,878.586207,574.032231,681.882